InvestorsHub Logo
Followers 51
Posts 1707
Boards Moderated 0
Alias Born 01/13/2014

Re: hovacre post# 37245

Thursday, 10/05/2017 9:00:37 AM

Thursday, October 05, 2017 9:00:37 AM

Post# of 108192
Have you heard or read anything about the safety profile of ADXS HER2 construct? I have read comments over the years that suggests it would be wildly effective, but could generate some side effects in humans, potentially dangerous for a certain small percentage of patients.

I bring this up as it relates to cost. Hypothetically if say 5% of the patients were at higher risk of life threatening complications, HER2 with legitimate life saving efficacy but side effects could still be approved (eventually) and be incredibly lucrative, but those trials and working with FDA thru the process could take some time and be very costly.

If that is true it would be logical to sell or license to a Big Pharma who could easily take on the heavy lifting and afford the cost.

Even if safety profile is no problem at all, it still makes sense to sell or license this out due to costs involved.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News